Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China · Delayed Price · Currency is CNY 54.40
-1.49 (-2.67%)
Jun 17, 2026, 11:24 AM CST
Xiamen Amoytop Biotech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 22,814 | 34,157 | 29,847 | 21,296 | 15,837 | 11,911 | |
Market Cap Growth | -21.30% | 14.44% | 40.15% | 34.47% | 32.96% | -14.13% |
Enterprise Value | 21,914 | 33,473 | 29,272 | 20,670 | 15,360 | 11,446 |
Last Close Price | 55.89 | 82.75 | 71.95 | 50.97 | 37.71 | 28.25 |
PE Ratio | 22.65 | 33.12 | 36.06 | 38.34 | 55.18 | 65.73 |
Forward PE | 17.88 | 28.12 | 28.12 | 28.12 | 28.12 | 28.12 |
PS Ratio | 5.97 | 9.24 | 10.60 | 10.14 | 10.37 | 10.52 |
PB Ratio | 6.28 | 9.90 | 11.69 | 11.35 | 11.25 | 10.26 |
P/TBV Ratio | 7.08 | 11.29 | 12.53 | 12.64 | 12.32 | 11.74 |
P/FCF Ratio | 59.15 | 72.18 | 166.48 | 95.23 | 109.98 | 271.61 |
P/OCF Ratio | 34.72 | 46.83 | 69.31 | 41.59 | 43.61 | 50.73 |
EV/Sales Ratio | 5.74 | 9.06 | 10.39 | 9.84 | 10.06 | 10.11 |
EV/EBITDA Ratio | 16.52 | 25.22 | 29.29 | 28.98 | 38.09 | 43.97 |
EV/EBIT Ratio | 18.36 | 27.58 | 31.46 | 31.32 | 42.66 | 51.64 |
EV/FCF Ratio | 56.81 | 70.73 | 163.28 | 92.42 | 106.67 | 260.99 |
Debt / Equity Ratio | 0.05 | 0.05 | 0.00 | 0.00 | 0.01 | 0.02 |
Debt / EBITDA Ratio | 0.14 | 0.13 | 0.01 | 0.01 | 0.02 | 0.10 |
Debt / FCF Ratio | 0.48 | 0.37 | 0.05 | 0.04 | 0.07 | 0.57 |
Net Debt / Equity Ratio | -0.25 | -0.24 | -0.26 | -0.35 | -0.40 | -0.39 |
Net Debt / EBITDA Ratio | -0.68 | -0.63 | -0.65 | -0.93 | -1.39 | -1.75 |
Net Debt / FCF Ratio | -2.33 | -1.77 | -3.64 | -2.96 | -3.90 | -10.41 |
Asset Turnover | 1.00 | 1.00 | 1.04 | 1.02 | 0.96 | 0.87 |
Inventory Turnover | 0.83 | 0.77 | 0.82 | 0.89 | 1.39 | 1.18 |
Quick Ratio | 3.92 | 3.23 | 3.55 | 2.80 | 3.04 | 4.01 |
Current Ratio | 4.79 | 3.86 | 4.34 | 3.32 | 3.57 | 4.71 |
Return on Equity (ROE) | 31.78% | 34.36% | 37.37% | 33.83% | 22.35% | 16.77% |
Return on Assets (ROA) | 19.52% | 20.43% | 21.51% | 19.99% | 14.09% | 10.59% |
Return on Invested Capital (ROIC) | 39.56% | 47.22% | 53.10% | 55.56% | 37.47% | 29.64% |
Return on Capital Employed (ROCE) | 30.70% | 33.10% | 35.40% | 33.80% | 24.00% | 17.80% |
Earnings Yield | 4.44% | 3.02% | 2.77% | 2.61% | 1.81% | 1.52% |
FCF Yield | 1.69% | 1.39% | 0.60% | 1.05% | 0.91% | 0.37% |
Dividend Yield | 1.09% | 0.75% | 0.86% | 0.80% | 0.56% | 0.35% |
Payout Ratio | 24.99% | 24.52% | 20.15% | 15.60% | 14.17% | 11.41% |
Buyback Yield / Dilution | -0.64% | -0.38% | -0.56% | -0.29% | -0.39% | -0.18% |
Total Shareholder Return | 0.45% | 0.37% | 0.31% | 0.51% | 0.17% | 0.18% |